July’s Master Class webinar takes a look at considerations for market access teams given the introduction of the EU Health Technology Assessment (HTA) process.

Key learnings:

• Understand latest status update on the introduction of the JCA/ EU HTA process
• Consider possible trajectories for the anticipated U.S. HTA body
• Review implications for European, U.S., and global market access strategies

Speakers

Debjani Rao
Sr. Principal, Value & Access Strategy Consulting, IQVIA

Rebecca Coady
Principal, Value & Payer Evidence Strategy Consulting, IQVIA